<DOC>
	<DOCNO>NCT01193179</DOCNO>
	<brief_summary>The purpose study investigate safety OPC-262 administer orally combination another oral antihyperglycemic agent</brief_summary>
	<brief_title>A Phase 3 Study OPC-262 Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>1 ) Patients capable give informed consent 2 ) Patients able take contraceptive measure avoid pregnancy patient patient 's partner Patients severe ketosis , diabetic coma precoma , type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>